Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
Calcium gluconate; Magnesium hypophosphite; Dextrose monohydrate; Boric acid
Norbrook Laboratories Limited
QA12AA20
Calcium gluconate; Magnesium hypophosphite; Dextrose monohydrate; Boric acid
Not Currently Available
Solution for injection
LM: Licensed Merchant as defined in relevant national legislation
Sheep
calcium (different salts in combination)
Vitamins and minerals
Authorised
1991-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Calciject PMD Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear pale yellow sterile aqueous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Calciject PMD is indicated in the treatment of hypocalcaemia complicated by a deficiency of magnesium with accompanying hypoglycaemia. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES No special warnings. Each ml contains: Active Substance Calcium Gluconate 166 mg Boric Acid 34 mg Dextrose Monohydrate 200 mg Magnesium Hypophosphite 50 mg (as hexahydrate) Excipients Chlorocresol (as preservative) 1 mg H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _8_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _3_ _8_ _3_ _1_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The solution should be warmed to body temperature before administration. Intravenous injections should be given slowly and stopped at the first signs of adverse reaction. Rapid intravenous injection may result in cardiac arrhythmias and, in severely toxaemic animals, collapse and death. As intravenous administration of this product could cause death, this route should only be used by a veterinary surgeon. SPECIAL Прочетете целия документ